Advertisement
Organisation › Details
Wilex (Group)
WILEX is a biopharmaceutical Company based in Munich, which was founded in 1997 by a team of physicians and oncologists from the Technical University of Munich. WILEX is focused on the development of new cancer therapies based on antibodies and small molecules. The therapeutic approach of WILEX targets the prevention of growth, spread and the metastasis of malignant tumours and the destruction of malig-nant tumours in the body. The portfolio includes both drug and medical product candidates ranging from research to late stage clinical development. Currently the following compounds are in clinical development: WX-G250 (development name: RENCAREX®), WX-671, WX-UK1 and CA9-SCAN. The company's strategy is to develop WILEX into a commercially successful biopharmaceutical company with a broad portfolio of new drugs and medical products for the treatment of cancer. *
Start | 1997-10-01 established | |
End | 2017-08-01 renamed | |
Group | Heidelberg Pharma (Group) | |
Today | Heidelberg Pharma (Group) | |
Successor | Heidelberg Pharma (Group) | |
Industry | cancer drug | |
Industry 2 | cancer test | |
Person | Schmidt-Brand, Jan (Wilex 201404– CEO before CFO + Heidelberg Pharma 200109– CEO + CFO) | |
Person 2 | Wilhelm, Olaf Georg (Therawis 201405– Managing Director before Wilex 2001–201403 CEO) | |
Region | München (Munich) | |
Country | Germany | |
Street | 10 Grillparzerstr. | |
City | 81675 München | |
Tel | +49-89-413138-0 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | C: 51 to 100 (2016-11-30) |
Currency | EUR | |
Annual sales | 2,743,458 (income, total, consolidated (2015/16) 2016-11-30) | |
Profit | -6,389,034 (2016-11-30) | |
Cash | 5,500,000 (2017-05-31) | |
* Document for »About Section«: | ||
Record changed: 2023-12-30 |
Advertisement
More documents for Heidelberg Pharma (Group)
- [1] Heidelberg Pharma AG. (11/29/23). "Press Release: Heidelberg Pharma Announces Changes to the Executive Management Board. CEO Dr. Jan Schmidt-Brand to Retire". Ladenburg....
- [2] Heidelberg Pharma AG. (6/29/23). "Press Release: Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics (ad hoc announcement)". Ladenburg....
- [3] Heidelberg Pharma AG. (9/9/22). "Press Release: Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate". Ladenburg....
- [4] Heidelberg Pharma AG. (8/30/22). "Press Release: Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure [ Not for US, CA, et al.]". Ladenburg....
- [5] Heidelberg Pharma AG. (7/13/22). "Press Release: Heidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreement for the Development of an Antibody Drug Conjugate (ad hoc)". Ladenburg....
- [6] Heidelberg Pharma AG. (3/10/22). "Press Release: Heidelberg Pharma Receives Milestone Payment from Partner Magenta for Dosing the First Patient with MGTA-117". Ladenburg....
- [7] Heidelberg Pharma AG. (2/28/22). "Press Release: Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment". Ladenburg....
- [8] Heidelberg Pharma AG. (2/17/22). "Press Release: Heidelberg Pharma AG Secures Financing Commitment From its Main Shareholder dievini (ad hoc)". Ladenburg....
- [9] ProBioGen AG. (10/22/20). "Press Release: Heidelberg Pharma Contracts ProBioGen for Cell Line Development and Manufacturing Services". Berlin....
- [10] Heidelberg Pharma AG. (4/27/20). "Press Release: Heidelberg Pharma AG Raises EUR 14.4 Million from Private Placement". Ladenburg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top